Quarry LP’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
Quarry LP's NPCE Position: Q2 2026 in Review
Quarry LP opened a new position in Neuropace (NPCE) in Q2 2026: 161 shares worth $2.56K. The stake represents ﹤0.01% of the portfolio and ranks #1478 among its holdings. This is a return to the name: Quarry LP previously reported a position in NPCE as recently as Q4 2025.
Quarry LP first reported a position in NPCE in Q2 2025 and has held it in 4 quarters since. The position peaked at $39.6K in Q3 2025. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.
- Quarry LP held 161 shares of Neuropace worth $2.56K as of Q2 2026.
- Neuropace was a new Quarry LP position in Q2 2026.
- Neuropace made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1478 holding.
- Quarry LP first reported a position in Neuropace in Q2 2025 and has held it in 4 quarters since.
- Quarry LP's Neuropace position peaked at $39.6K in Q3 2025.
- 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.
Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.